ATE236142T1 - C7-taxan-derivate sowie diese enthaltende arzneimittel - Google Patents

C7-taxan-derivate sowie diese enthaltende arzneimittel

Info

Publication number
ATE236142T1
ATE236142T1 AT94909514T AT94909514T ATE236142T1 AT E236142 T1 ATE236142 T1 AT E236142T1 AT 94909514 T AT94909514 T AT 94909514T AT 94909514 T AT94909514 T AT 94909514T AT E236142 T1 ATE236142 T1 AT E236142T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
taxan derivatives
derivatives
taxan
Prior art date
Application number
AT94909514T
Other languages
English (en)
Inventor
Robert A Holton
Ki-Byung East Paul Chai
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Univ Florida State filed Critical Univ Florida State
Application granted granted Critical
Publication of ATE236142T1 publication Critical patent/ATE236142T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/62Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94909514T 1993-01-29 1994-01-28 C7-taxan-derivate sowie diese enthaltende arzneimittel ATE236142T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9516093A 1993-07-20 1993-07-20
PCT/US1994/001059 WO1994017050A1 (en) 1993-01-29 1994-01-28 C7 taxane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ATE236142T1 true ATE236142T1 (de) 2003-04-15

Family

ID=27359310

Family Applications (3)

Application Number Title Priority Date Filing Date
AT01102160T ATE243205T1 (de) 1993-01-29 1994-01-28 C7-taxan-derivate und diese enthaltende pharmazeutische zusammensetzungen
AT02023352T ATE341321T1 (de) 1993-01-29 1994-01-28 Zusammenstellungen enthaltend c7 taxane
AT94909514T ATE236142T1 (de) 1993-01-29 1994-01-28 C7-taxan-derivate sowie diese enthaltende arzneimittel

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT01102160T ATE243205T1 (de) 1993-01-29 1994-01-28 C7-taxan-derivate und diese enthaltende pharmazeutische zusammensetzungen
AT02023352T ATE341321T1 (de) 1993-01-29 1994-01-28 Zusammenstellungen enthaltend c7 taxane

Country Status (12)

Country Link
EP (3) EP1108717B1 (de)
JP (2) JPH08506324A (de)
AT (3) ATE243205T1 (de)
AU (1) AU689099B2 (de)
CA (1) CA2155018C (de)
DE (3) DE69432404T2 (de)
DK (3) DK0681574T3 (de)
ES (3) ES2191029T3 (de)
IL (1) IL108443A0 (de)
PT (3) PT681574E (de)
TW (1) TW492963B (de)
WO (1) WO1994017050A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
EP0788493A1 (de) * 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid-derivate, deren herstellung und deren verwendung als anti-tumor-mittel
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
HUP0600302A2 (en) * 2000-02-02 2006-07-28 Univ Florida State Res Found C10 ester substituted taxanes as antitumor agents
WO2001057029A1 (en) * 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
US6362217B2 (en) 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents
BR0313197A (pt) 2002-08-02 2005-08-09 Immunogen Inc Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
DE69230379T2 (de) * 1991-09-23 2000-05-25 Bristol-Myers Squibb Co., New York 10-disacetoxytaxolderivate
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5248796A (en) * 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State C10 taxane derivatives and pharmaceutical compositions containing them
IL108444A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C2 taxane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1994017050A1 (en) 1994-08-04
EP0681574A4 (de) 1995-12-13
DE69432835D1 (de) 2003-07-24
PT1275389E (pt) 2006-12-29
ES2199901T3 (es) 2004-03-01
JPH08506324A (ja) 1996-07-09
DE69432835T2 (de) 2004-04-22
ES2267921T3 (es) 2007-03-16
JP3940392B2 (ja) 2007-07-04
ATE341321T1 (de) 2006-10-15
PT681574E (pt) 2003-09-30
EP0681574B1 (de) 2003-04-02
EP1275389A1 (de) 2003-01-15
EP1275389B1 (de) 2006-10-04
CA2155018A1 (en) 1994-08-04
EP1108717B1 (de) 2003-06-18
ATE243205T1 (de) 2003-07-15
DK0681574T3 (da) 2003-07-28
IL108443A0 (en) 1994-04-12
DE69434861D1 (de) 2006-11-16
AU689099B2 (en) 1998-03-26
CA2155018C (en) 2006-11-28
EP1108717A3 (de) 2001-08-29
DE69434861T2 (de) 2007-04-26
EP0681574A1 (de) 1995-11-15
TW492963B (en) 2002-07-01
ES2191029T3 (es) 2003-09-01
DE69432404T2 (de) 2003-10-30
EP1108717A2 (de) 2001-06-20
DE69432404D1 (de) 2003-05-08
DK1275389T3 (da) 2007-02-12
JP2004043499A (ja) 2004-02-12
PT1108717E (pt) 2003-11-28
AU6233794A (en) 1994-08-15
DK1108717T3 (da) 2003-10-13

Similar Documents

Publication Publication Date Title
DE69432404D1 (de) C7-Taxan-Derivate sowie diese enthaltende Arzneimittel
NO943002D0 (no) Fosfono-oksymetyletere av taxanderivater
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
ATE216590T1 (de) Arzneimittelformulierungen für il-12
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ATE197897T1 (de) Hautpflegemittel
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
LU90366I2 (fr) Nasonex
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2071939T3 (es) Nuevos productos esteroides que comprenden un radical espiro en posicion 17, su procedimiento de preparacion y los productos intermedios de este procedimiento, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.
ATE223427T1 (de) Modifizierte kojibioside analoge
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
DE59005487D1 (de) Phenylhydrazone des beta-Jonons, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika.
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them
IT1254742B (it) Impiego della beta-endorfina quale farmaco immunosoppressore nei trapianti d'organo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0681574

Country of ref document: EP

REN Ceased due to non-payment of the annual fee